Abstract
PURPOSE: To provide the wound care practitioner with an overview of research and knowledge about the causes, mechanisms, contributing factors, and management of acute wound pain.
TARGET AUDIENCE: This continuing education activity is intended for physicians and nurses with an interest in skin and wound care.
OBJECTIVES: After reading this article and taking this test, the reader should be able to:
1. Describe the causes of acute wound pain.
2. Discuss research findings related to the physiology of wound pain.
3. Identify current concepts in the management of acute wound pain.
INTRODUCTION
Acute wounds that occur as a result of surgery or trauma are associated with moderate to severe pain.1-3 Recent evidence suggests that unrelieved pain can interfere with the wound-healing process. For example, women with higher pain intensity scores experienced delays in wound healing after elective gastric bypass surgery.4 In addition, unrelieved postoperative pain and hyperalgesia may be risk factors for the development of chronic postsurgical pain.5,6
Despite the large numbers of patients who undergo surgery or experience traumatic injuries, the majority of the literature on wound pain is focused on chronic wounds. Therefore, this article will discuss the causes of acute wound pain, the mechanisms of and the factors that contribute to acute wound pain, and the management of acute wound pain.
CAUSES OF ACUTE WOUND PAIN
Acute wounds heal in a timely manner7 and most commonly are a result of surgical or traumatic origin. Acute wound pain (ie, pain at the site or around an acute wound) can occur spontaneously or result from an activity or procedure. The World Union of Wound Healing Societies categorized the causes of wound pain as background, incident, procedural, and operative.8
Definitions and research findings on the causes of wound pain are summarized in Table 1. Not surprisingly, Table 1 shows that level of pain depends on the causes of pain. In both acute and chronic wounds, background pain (ie, pain at rest) ranges from mild to moderate. Incident pain (eg, pain while coughing), procedural pain (eg, pain during dressing removal), and operative pain (eg, wound debridement) are worse than pain at rest.
![]() | Table 1. DEFINITIONS AND RESEARCH FINDINGS ON THE CAUSES OF PAIN ASSOCIATED WITH ACUTE WOUNDS |
MECHANISMS OF WOUND PAIN
Mechanisms that underlie the development of acute wound pain have been identified in experimental and clinical models of surgical wounds. Although many studies have attempted to determine the mechanisms involved in wound pain, these mechanisms remain poorly understood.9 Apparently, more than 1 mechanism is involved in wound pain. For example, incisional pain may involve nociceptive, inflammatory, and neuropathic pain.10 However, a recent review11 suggests that the ischemic pain mechanism may be responsible for incisional pain. The following sections of this article will summarize the 3 major types of pain, the concepts of peripheral and central sensitizations in relationship to acute wound pain, and factors that can contribute to acute wound pain.
Nociceptive pain. As illustrated in Figure 1, nociceptive pain occurs immediately after exposure to a noxious stimulus (eg, thermal, mechanical, chemical), and it is necessary to prevent further tissue damage.12 Nociceptive pain is mediated through the peripheral (ie, A-delta [A-[delta]] and C fibers) and central nervous systems through the processes of transduction, transmission, modulation, and perception.
![]() | Figure 1. NOCICEPTIVE PAIN MECHANISMAbbreviations: A[delta] = A-delta fibers; C = C fibers. |
Transduction converts a peripheral noxious stimulus into electrical activity. The electrical signal is transmitted from the peripheral nervous system to the central nervous system initiated by neurotransmitters found in the spinal cord, brain stem and thalamus, and cerebral cortex.12,13
Modulation refers to the facilitation or inhibition of pain impulses sent to the brain. Modulation occurs directly at the level of the spinal cord and through descending pathways from the midbrain periaqueductal gray region, pons, and medulla to the dorsal horn.12,14,15 In addition to these areas, the thalamus and cortex are involved in pain modulation.16 Finally, perception refers to the interpretation of the nociceptive signal as pain.10
Inflammatory pain. Inflammatory pain arises when tissue damage occurs due to surgery, trauma, or other inflammatory conditions.12 This pain usually resolves when the condition that provokes the inflammation is controlled.17 Inflammation is characterized by redness (rubor), heat (calor), and swelling (tumor).14
Inflammatory pain follows the same pathways and processes as nociceptive pain but is associated with peripheral sensitization and central sensitization.12 According to Meyer et al,18 "sensitization is characterized by a decrease in threshold, an augmented response to suprathreshold stimuli,and ongoing spontaneous activity." As illustrated in Figure 2, peripheral sensitization occurs when tissue damage induces the release of chemical mediators from different cells and/or tissue-damaged sites that activate or sensitize the nociceptors.12,14,18,19 As a consequence of nociceptor sensitization, the process of transduction is altered, and the conduction of the electrical impulse increases.20 In addition, the activation threshold of nociceptors decreases, which results in allodynia (ie, pain caused by a stimulus that normally is not noxious).14,21 These physiological processes result in primary hyperalgesia, a condition in which the site of injury or inflammation has increased sensitivity to pain.12,18
![]() | Figure 2. PERIPHERAL AND CENTRAL SENSITIZATION MECHANISMSAbbreviations: [up arrow] = increase; A[delta] = A-delta fibers; C = C fibers; NMDA = |
As part of inflammatory pain, central sensitization can occur. In this process, dorsal horn neurons are activated through the release of neurotransmitters from primary afferent nociceptors.12,19 These neurotransmitters stimulate dorsal horn neurons to become hyperresponsive to noxious stimuli, leading to an increase in pain transmission.12N-methyl-D-aspartate (NMDA)-type glutamate receptors participate in the hyperresponsiveness of second-order neurons.14 With central sensitization, secondary hyperalgesia and allodynia occur in uninjured areas surrounding the site of injury.18
Neuropathic pain. Neuropathic pain is caused by lesions in the peripheral or central nervous systems.17 Similar to inflammatory pain, both peripheral and central sensitizations occur, which are characterized by primary and secondary hyperalgesias, respectively.12 Neuropathic pain can occur spontaneously or be provoked by an external stimulus.12 However, unlike inflammatory pain, temporary or permanent changes can occur within the peripheral and central nervous systems, and this can result in chronic pain.6,17
Role of peripheral and central sensitizations in acute wound pain. Although it remains a topic of debate, recent studies suggest that both peripheral and central sensitizations contribute to the symptoms of primary and secondary hyperalgesias associated with incisional pain.10,11 Sensitization can contribute to increases in the severity of wound pain owing to augmentation of noxious inputs.22 Both primary and secondary hyperalgesias were demonstrated in a rat model of incisional pain (plantar aspect of the foot)23 and in human experimental models (small incision through the skin, fascia, and muscle).24 In addition, secondary hyperalgesia was found in the area surrounding an incision in patients who underwent nephrectomy25 and abdominal hysterectomy.26
The mechanisms that underlie the development and maintenance of peripheral and central sensitizations (ie, primary and secondary hyperalgesias) are not well understood. Kawamata et al24 established that secondary hyperalgesia is mediated by peripheral sensitization. After an incision is performed, A-[delta] and C fibers are sensitized and generate spontaneous activities that amplify the responses of dorsal horn neurons.27 Silent nociceptors, which normally do not respond to noxious stimuli, can become activated and contribute to the development of both primary and secondary hyperalgesias.24,28 Finally, an innocuous stimulus can be transformed to evoke allodynia through an increase in the responses of nociceptors, sensitization of silent nociceptors, and an increase in the receptive field of A-[delta] and C fibers.29 Although the specific mechanisms remain unclear, both peripheral and central mechanisms may contribute to the maintenance of secondary hyperalgesia.24 A comparison of the type of pain, characteristic of pain, and clinical symptoms among the 4 causes of wound pain is presented in Table 2.
![]() | Table 2. OVERVIEW OF WOUND PAIN |
Factors that contribute to acute wound pain. Many factors can contribute to the development of both peripheral and central sensitizations and, consequently, wound pain. These factors can be categorized as "wound-direct" and "wound-indirect" (Figure 3).
![]() | Figure 3. FACTORS THAT CONTRIBUTE TO ACUTE WOUND PAINAbbreviations: # = number; 1° = primary; 2° = secondary. |
Wound-direct factors. Brennan9 suggested that factors associated with the surgical wound contribute to the development of sensitization. Wound-direct factors include acidosis at the wound site, infection, inflammation, size, and location of the wound. Recent findings suggest that acidosis at the site of the wound induces sensitization of nociceptors.30,31 In a rodent model, the development of tissue acidosis after an incision resulted in increased pain behaviors. Rodent pain behaviors decreased when tissue pH levels became normal.31 Kim et al30 suggested that both a decrease in pH levels and an increase in tissue lactate concentration after incision contributed to incisional pain through the induction of ischemia.
Acute wounds are at risk for infection, and wound infection is usually associated with increased pain at the site of the wound. In fact, 1 criterion for diagnosis of an acute wound infection is pain.32 Infection-causing bacteria produce endotoxins and exotoxins, both of which injure tissue33 and may contribute to sensitization. Infection leads to an inflammatory response that releases the inflammatory soup (ie, the several chemical mediators) that induces nociceptor sensitization.
The association between pain and wound size is not well studied. However, in 1 study,2 patients with larger acute wounds reported higher pain intensity scores. It is possible that if the area of the wound is large, more nociceptors are activated and sensitized.
The location of the wound is another factor that is associated with differences in pain intensity. Some wounds are located in areas that involve major peripheral nerves (eg, thorax, breast, groin). These nerves can be damaged during surgical procedures, and this damage can contribute to the development of neuropathic pain as well as hyperalgesia and allodynia.34
Wound-indirect factors. A variety of indirect factors can contribute to pain in acute wounds including repetitive stimuli, cleansing solutions, the primary dressing (ie, dressing applied directly to the wound bed), and the length of time from injury. Repetitive stimulation associated with respiratory movements and coughing, especially following thoracic or abdominal surgery, may contribute to peripheral and central sensitization.24 In addition, wound care that includes removal of the dressing, local care applied to the wound, and reapplication of a dressing may also stimulate or traumatize the wound area and enhance sensitization. Trauma to the wound during local care can be done by mechanical (ie, scrubbing or high-pressure irrigation) or chemical (ie, toxic cleansing solutions) means.35
Numerous solutions are available to clean a wound. However, some solutions (eg, povidone-iodine, acetic acid, hydrogen peroxide, sodium hypochlorite) have antiseptic properties that are toxic to wound cells36,37 and may lead to sensitization of nociceptors. Some of these solutions, as well as other products, are often used as part of the primary dressing. Jurczak et al38 found that the overall ability to manage open surgical or traumatic wound pain was rated significantly (P < .01) better in patients using a hydrofiber with silver dressing than in patients using providone-iodine gauze as the primary dressing. Patients with open wounds from excision of a pilonidal sinus treated with hydrocolloids reported significantly less pain (P = .05) compared with those treated with povidone-iodine gauze.39 In the study by Meaume et al,2 95% of patients reported no pain or less pain during dressing removal when they were treated with a lipidocolloid contact layer dressing compared with wet, dry, or paraffin gauze. The use of wet or dry gauzes and gauzes impregnated in antiseptic solutions (eg, sodium hypochlorite and povidone-iodine) as primary dressings enhance wound pain.40 These dressings often dry out and adhere to the wound bed, traumatizing it when they are removed, thereby sensitizing nociceptors.
The length of time from injury is another factor that contributes to sensitization and wound pain. Wounds are more painful during the inflammatory phase of healing than during the active repair phases.40,41 Mechanisms that may contribute to increased pain include inflammation, wound hypoxia, and exposed nerve endings.40 Patients with acute wounds reported severe pain when the wound had less time from injury (P < .001).2 Patients who underwent a hysterectomy were evaluated preoperatively and at different postoperative times for pain intensity using a 0- to 100-mm visual analog scale. Pain intensity at rest was significantly higher at 4 hours (42 mm), 6 hours (22 mm), and the first day (21 mm), decreasing gradually to 0 mm by the fourth postoperative day.42 Their pain intensity during coughing gradually decreased (88 mm at 4 hours, 85 mm at 8 hours, 51 mm at the first day, and 45 mm at the fourth day), but was still significantly higher up to the eighth day (33 mm) when compared with preoperative pain intensity (0 mm).
PAIN MANAGEMENT FOR ACUTE WOUNDS
Pain management for acute wounds should focus on the use of strategies that will attenuate modifiable factors that contribute to wound pain, such as infection, repetitive stimuli, cleansing solutions, and primary dressing (Table 3). These strategies involve both pharmacological and nonpharmacological interventions that need to be individualized. Pharmacological treatments will vary based on the different types, causes, and severity of the pain. Whereas moderate to severe nociceptive pain is usually managed with opioids (eg, morphine, fentanyl, oxycodone with acetaminophen), inflammatory pain responds better to nonsteroidal anti-inflammatory drugs (NSAIDs). However, clinicians need to exercise caution with the use of NSAIDs, specifically selective cyclooxygenase-2 inhibitors, which may increase the risk for cardiovascular events in some patients.43 Neuropathic pain is treated with coanalgesics, such as antidepressants and anticonvulsants. Nonetheless, because acute wound pain may involve multiple mechanisms, the use of a combination of analgesics is recommended.10
![]() | Table 3. STRATEGIES DIRECTED AT ATTENUATING MODIFIABLE WOUND FACTORS |
Ketamine, another pharmacological agent, has been a focus of study to prevent or treat central sensitization (ie, decrease secondary hyperalgesia) in the postoperative period.25,44 Ketamine is an NMDA noncompetitive receptor antagonist that has antihyperalgesic and analgesic properties at subanesthetic doses (ie, small doses). In several clinical trials,45-47 small doses of ketamine in combination with opioids decreased postoperative pain. Although ketamine has been associated with psychomimetic adverse effects,48 in a systematic review49 of randomized, double-blind clinical trials of perioperative pain management, the incidence of central nervous system adverse effects did not differ between patients who received an opioid with a small dose of ketamine compared with patients who received only an opioid.
It is imperative to consider the causes of wound pain to provide adequate pain management. Because background pain can be continuous, the administration of analgesics "around the clock" is recommended, instead of "as needed," to maintain a steady analgesic level.50 In addition to an analgesic given to decrease background pain, it is necessary to administer rescue doses for incident pain. In terms of procedural and operative pain, it is critical to know the pharmacokinetics (ie, time to peak analgesic effect, duration of analgesia) of the various analgesics to determine the correct time to administer the agents to prevent pain.
CONCLUSION
Acute wound pain is common in patients with surgical and traumatic wounds. The principal causes of acute wound pain are background, incident, and procedural pain. Different mechanisms underlie acute wound pain including nociceptive, inflammatory, neuropathic, and ischemic. Wound pain can be a consequence of 1 or all of these mechanisms.
Research has advanced the wound care practitioner's knowledge of pain mechanisms. Nevertheless, there are still gaps in the research that require further attention. For example, clinical studies could target wound-direct and wound-indirect factors and could contribute to the understanding of the perception of pain, as well as to the development of clinical symptoms, such as hyperalgesia and allodynia. Furthermore, research could investigate the best pharmacological therapies to treat background, incident, and procedural wound pain. Acute wound pain is not only distressing; it can also develop into chronic pain if ineffectively treated.
Pain research can contribute to a better understanding of the mechanisms involved in different clinical situations that evoke wound pain, as well as promote the development of new pharmacological therapies to improve a patient's pain experience. The translation of these research findings into clinical practice can contribute to the improvement of wound pain assessment and management, eventually achieving better patient outcomes.
REFERENCES
1. Apfelbaum JL, Chen C, Mehta SS, Gan TJ. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg 2003;97:534-40. [Context Link]
2. Meaume S, Téot L, Lazareth I, Martini J, Bohbot S. The importance of pain reduction through dressing selection in routine wound management: the MAPP study. J Wound Care 2004;13:409-13. [Context Link]
3. Shukla D, Tripathi AK, Agrawal S, Ansari MA, Rastogi A, Shukla VK. Pain in acute and chronic wounds: a descriptive study. Ostomy Wound Manage 2005;51(11):47-51. [Context Link]
4. McGuire L, Heffner K, Glaser R, et al. Pain and wound healing in surgical patients. Ann Behav Med 2006;31:165-72. [Context Link]
5. Lavand'homme P, De Kock M, Waterloos H. Intraoperative epidural analgesia combined with ketamine provides effective preventive analgesia in patients undergoing major digestive surgery. Anesthesiology 2005;103:813-20. [Context Link]
6. Perkins FM, Kehlet H. Chronic pain as an outcome of surgery. A review of predictive factors. Anesthesiology 2000;93:1123-33. [Context Link]
7. Lazarus GS, Cooper DM, Knighton DR, Percoraro RE, Rodeheaver G, Robson MC. Definitions and guidelines for assessment of wounds and evaluation of healing. Wound Repair Regen 1994;2:165-70. [Context Link]
8. World Union of Wound Healing Societies. Principles of Best Practice: Minimising Pain at Wound Dressing-Related Procedures. A Consensus Document. London: MEP Ltd; 2004. http://www.wuwhs.org . Last accessed May 26, 2009. [Context Link]
9. Brennan TJ. Frontiers in translational research: the etiology of incisional and postoperative pain. Anesthesiology 2002;97:535-7. [Context Link]
10. Dahl JB, Kehlet H. Postoperative pain and its management. In: McMahon SB, Koltzenburg M, eds. Wall and Melzack's Textbook of Pain. 5th ed. Philadelphia, PA: Elsevier/Churchill Livingstone; 2006:635-51. [Context Link]
11. Pogatzki-Zahn EM, Zahn PK, Brennan TJ. Postoperative pain: clinical implications of basic research. Best Pract Res Clin Anaesthesiol 2007;21:3-13. [Context Link]
12. Woolf CJ; American College of Physicians; American Physiological Society. Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med 2004;140:441-51. [Context Link]
13. Fields HL. Pain. New York, NY: McGraw-Hill Book Co; 1987. [Context Link]
14. Basbaum AI, Jessell TM. The perception of pain. In: Kandel ER, Schwartz JH, Jessell TM, eds. Principles of Neural Science. 4th ed. New York, NY: McGraw-Hill, Health Professions Division; 2000:472-91. [Context Link]
15. Hunt SP, Mantyh PW. The molecular dynamics of pain control. Nat Rev Neurosci 2001;2:83-91. [Context Link]
16. Bushnell MC, Apkarian AV. Representation of pain in the brain. In: McMahon SB, Koltzenburg M, eds. Wall and Melzack's Textbook of Pain. 5th ed. Philadelphia, PA: Elsevier/Churchill Livingstone; 2006:107-24. [Context Link]
17. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000;288:1765-9. [Context Link]
18. Meyer RA, Ringkamp M, Campbell JN, Raja SN. Peripheral mechanisms of cutaneous nociception. In: McMahon SB, Koltzenburg M, eds. Wall and Melzack's Textbook of Pain. 5th ed. Philadelphia, PA: Elsevier/Churchill Livingstone; 2006:3-34. [Context Link]
19. Scholz J, Woolf CJ. Can we conquer pain? Nat Neurosci 2002;5 Suppl:1062-7. [Context Link]
20. Dahl JB, Møiniche S. Pre-emptive analgesia. Br Med Bull 2004;71:13-27. [Context Link]
21. Julius D, Basbaum AI. Molecular mechanisms of nociception. Nature 2001;413:203-10. [Context Link]
22. Wilder-Smith OH, Arendt-Nielsen L. Postoperative hyperalgesia: its clinical importance and relevance. Anesthesiology 2006;104:601-7. [Context Link]
23. Zahn PK, Brennan TJ. Primary and secondary hyperalgesia in a rat model for human postoperative pain. Anesthesiology 1999;90:863-72. [Context Link]
24. Kawamata M, Watanabe H, Nishikawa K, et al. Different mechanisms of development and maintenance of experimental incision-induced hyperalgesia in human skin. Anesthesiology 2002;97:550-9. [Context Link]
25. Stubhaug A, Breivik H, Eide PK, Kreunen M, Foss A. Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery. Acta Anaesthesiol Scand 1997;41:1124-32. [Context Link]
26. Dirks J, Møiniche S, Hilsted KL, Dahl JB. Mechanisms of postoperative pain: clinical indications for a contribution of central neuronal sensitization. Anesthesiology 2002;97:1591-6. [Context Link]
27. Pogatzki EM, Gebhart GF, Brennan TJ. Characterization of A-delta and C fibers innervating the plantar rat hindpaw one day after an incision. J Neurophysiol 2002;87:721-31. [Context Link]
28. Zahn PK, Pogatzki EM, Brennan TJ. Mechanisms for pain caused by incisions. Reg Anesth Pain Med 2002;27:514-6. [Context Link]
29. Brennan TJ, Zahn PK, Pogatzki-Zahn EM. Mechanisms of incisional pain. Anesthesiol Clin North America 2005;23:1-20. [Context Link]
30. Kim TJ, Freml L, Park SS, Brennan TJ. Lactate concentrations in incisions indicate ischemic-like conditions may contribute to postoperative pain. J Pain 2007;8:59-66. [Context Link]
31. Woo YC, Park SS, Subieta AR, Brennan TJ. Changes in tissue pH and temperature after incision indicate acidosis may contribute to postoperative pain. Anesthesiology 2004;101:468-75. [Context Link]
32. Centers for Disease Control and Prevention. Guideline for prevention of surgical site infection. 1999. http://www.cdc.gov/ncidod/dhqp/gl_surgicalsite.html . Last accessed May 26, 2009. [Context Link]
33. Rote NS, Huether SE. Infection. In: McCance KL, Huether SE, eds. Pathophysiology: The Biologic Basis for Disease in Adults and Children. 5th ed. St Louis, MO: Elsevier Mosby; 2006:293-309. [Context Link]
34. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet 2006;367:1618-25. [Context Link]
35. Rodeheaver GT, Ratliff CR. Wound cleansing, wound irrigation, wound disinfection. In: Krasner DL, Rodeheaver GT, Sibbald RG, eds. Wound Care: A Clinical Source Book for Healthcare Professionals. 4th ed. Malvern, PA: HMP Communications; 2007:331-42. [Context Link]
36. Lineaweaver W, Howard R, Soucy D, et al. Topical antimicrobial toxicity. Arch Surg 1985;120:267-70. [Context Link]
37. Wilson JR, Mills JG, Prather ID, Dimitrijevich SD. A toxicity index of skin and wound cleansers used on in vitro fibroblasts and keratinocytes. Adv Skin Wound Care 2005;18:373-8. [Context Link]
38. Jurczak F, Dugré T, Johnstone A, Offori T, Vujovic Z, Hollander D; AQUACEL Ag Surgical/Trauma Wound Study Group. Randomised clinical trial of hydrofiber dressing with silver versus povidone-iodine gauze in the management of open surgical and traumatic wounds. Int Wound J 2007;4:66-76. [Context Link]
39. Viciano V, Castera JE, Medrano J, et al. Effect of hydrocolloid dressings on healing by second intention after excision of pilonidal sinus. Eur J Surg 2000;166:229-32. [Context Link]
40. Krasner DL, Shapshak D, Hopf HW. Managing wound pain. In: Bryant RA, Nix DP, eds. Acute and Chronic Wounds: Current Management Concepts. 3rd ed. St Louis, MO: Mosby Elsevier; 2006:539-65. [Context Link]
41. van Rijswijk L. Wound pain. In: McCaffery M, Pasero C, eds. Pain: Clinical Manual. 2nd ed. St Louis, MO: Mosby Inc; 1999:592-5. [Context Link]
42. Møiniche S, Dahl JB, Erichsen CJ, Jensen LM, Kehlet H. Time course of subjective pain ratings, and wound and leg tenderness after hysterectomy. Acta Anaesthesiol Scand 1997;41:785-9. [Context Link]
43. Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA; American Heart Association. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 2007;115:1634-42. [Context Link]
44. De Kock MF, Lavand'homme PM. The clinical role of NMDA receptor antagonists for the treatment of postoperative pain. Best Pract Res Clin Anaesthesiol 2007;21:85-98. [Context Link]
45. Dahl V, Ernoe PE, Steen T, Raeder JC, White PF. Does ketamine have preemptive effects in women undergoing abdominal hysterectomy procedures? Anesth Analg 2000;90:1419-22. [Context Link]
46. Suzuki M, Tsueda K, Lansing PS, et al. Small-dose ketamine enhances morphine-induced analgesia after outpatient surgery. Anesth Analg 1999;89:98-103. [Context Link]
47. Weinbroum AA. A single small dose of postoperative ketamine provides rapid and sustained improvement in morphine analgesia in the presence of morphine-resistant pain. Anesth Analg 2003;96:789-95. [Context Link]
48. White PF, Way WL, Trevor AJ. Ketamine: its pharmacology and therapeutic uses. Anesthesiology 1982;56:119-36. [Context Link]
49. Subramaniam K, Subramaniam B, Steinbrook RA. Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review. Anesth Analg 2004;99:482-95. [Context Link]
50. American Pain Society. Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain. 5th ed. Glenview, IL: American Pain Society; 2003. [Context Link]
51. Gilron I, Tod D, Goldstein DH, Parlow JL, Orr E. The relationship between movement-evoked versus spontaneous pain and peak expiratory flow after abdominal hysterectomy. Anesth Analg 2002;95:1702-7.
52. Stotts NA, Puntillo K, Bonham Morris A, et al. Wound care pain in hospitalized adult patients. Heart Lung 2004;33:321-32.












